WELLS FARGO & COMPANY/MN - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 72 filers reported holding SURFACE ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$765
+26.9%
880
+1.9%
0.00%
Q1 2023$603
-3.1%
864
+13.8%
0.00%
Q4 2022$622759
+3.3%
0.00%
Q3 2022$0
-100.0%
735
+9.1%
0.00%
Q2 2022$1,000
-99.7%
674
-99.5%
0.00%
Q1 2022$384,000
-41.5%
130,725
-4.8%
0.00%
Q4 2021$656,000
-75.5%
137,367
-61.1%
0.00%
-100.0%
Q3 2021$2,673,000
+5141.2%
353,062
+5071.6%
0.00%
Q2 2021$51,000
-79.5%
6,827
-78.6%
0.00%
Q1 2021$249,000
-21.7%
31,842
-7.9%
0.00%
Q4 2020$318,000
+31700.0%
34,579
+26499.2%
0.00%
Q3 2020$1,000130
+103.1%
0.00%
Q2 2020$064
+1.6%
0.00%
Q1 2020$0
-100.0%
63
-88.9%
0.00%
Q2 2019$2,000
-97.7%
568
-96.9%
0.00%
Q1 2019$88,000
-1.1%
18,408
-11.8%
0.00%
Q4 2018$89,000
+641.7%
20,882
+1781.3%
0.00%
Q3 2018$12,000
-20.0%
1,110
+24.6%
0.00%
Q2 2018$15,0008910.00%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q1 2023
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders